Medpace Holdings Inc. (MEDP)

$358.27

up-down-arrow $30.03 (9.15%)

As on 06-Nov-2024 16:00EST

Medpace Holdings Inc. (MEDP) Share Price

High:loading Low:loading Return: loading

Max:loading Min:loading Median:loading

Max:loading Min:loading Median:loading

loading...
loading...
loading...
loading...

Stock Range

Today’s Range
Low: 336.38 High: 360.90
52 Week Range
Low: 268.16 High: 459.77
Liquidityliquidity Low
Low Moderate High

Fundamentals

  • Market capMarket cap information

    $10,202 Mln

  • P/E RatioP/E Ratio information

    28.74

  • P/B RatioP/B Ratio information

    11.57

  • Industry P/EIndustry P/E information

    --

  • Debt to EquityDebt to Equity information

    0

  • ROEROE information

    0.54 %

  • ROCEROCE information

    --

  • Div. YieldDiv. Yield information

    0 %

  • Book ValueBook Value information

    --

  • EPSEPS information

    --

10 Years Aggregate

CFO

$2,050.46 Mln

EBITDA

$1,684.51 Mln

Net Profit

$1,057.34 Mln

Performance

YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Medpace Holdings (MEDP)
16.88 4.44 -4.97 30.66 16.63 36.57 --
BSE Sensex*
10.11 -2.63 1.21 22.45 9.81 14.47 11.04
S&P Small-Cap 600#
-5.82 -5.34 -13.73 -6.30 5.30 2.98 5.53
As on 06-Nov-2024  |  *As on 07-Nov-2024  |  #As on 26-Oct-2023
2023
2022
2021
2020
2019
2018
2017
Medpace Holdings (MEDP)
44.31 -2.40 56.35 65.60 58.81 45.67 0.53
S&P Small-Cap 600
13.89 -17.42 25.27 9.57 20.86 -9.70 11.73
BSE Sensex
18.74 4.44 21.99 15.75 14.38 5.87 27.91

Essential Checks View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials Detailed View

loading...

*All values are in ($ Mln)

loading...

*All values are in ($ Mln)

loading...

*All values are in ($ Mln)

Key Ratios view all

loading...

loading...

loading...

3Y Avg -- 5Y Avg -- TTM --

loading...
P/E Ratio

--

--Min --Median --Max

loading...
P/B Ratio

--

--Min --Median --Max

loading...
Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peer view all

Company
Price ($) Market Cap ($ Mln) P/E Ratio ROE
35.51 9,792.50 22.12 21.21
60.63 7,438.96 19.36 124.49
89.44 9,460.96 -- -9.9
65.87 7,202.11 -- -10.75

Shareholding Pattern Detailed Holdings

loading...

About The Company More Details

Chairman & CEO

Dr. August James Troendle M.D.

Chairman & CEO

Dr. August James Troendle M.D.

Headquarters

Cincinnati, OH
Edit peer-selector-edit
loading...
loading...

Key Facts

  • Market cap market-cap-information $10,202.22 Mln
  • Revenue (TTM)revenue-information $2,070.87 Mln
  • Earnings (TTM) earning-information $0.00 Mln
  • Cash date-information $656.90 Mln
  • Total Debt info $128.28 Mln
  • Insider's Holding 17.75%
  • Liquidity liquidity Low
  • 52 Week range week-range $268.16 - 459.77
  • Shares outstanding share-outstanding 31,081,600
  • 10 Years Aggregate:

    CFO: $2,050.46 Mln

    EBITDA: $1,684.51 Mln

    Net Profit: $1,057.34 Mln

About The Company

  • IPO Date 11-Aug-2016
  • Chairman & CEO Dr. August James Troendle M.D.
  • Chairman & CEO Dr. August James Troendle M.D.
  • Listing key-listing NASDAQ: MEDP
  • Country United States
  • Headquarters headquarters Cincinnati, OH
  • Website website https://www.medpace.com
  • Business

    Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in...  various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio. Address: 5375 Medpace Way, Cincinnati, OH, United States, 45227  Read more

FAQs for Medpace Holdings Inc. (MEDP)

The total asset value of Medpace Holdings Inc (MEDP) stood at $ 3,117 Mln as on 30-Sep-24

The share price of Medpace Holdings Inc (MEDP) is $358.27 (NASDAQ) as of 06-Nov-2024 16:00 EST. Medpace Holdings Inc (MEDP) has given a return of 16.63% in the last 3 years.

Medpace Holdings Inc (MEDP) has a market capitalisation of $ 10,202 Mln as on 06-Nov-2024. As per Value Research classification, it is a Small Cap company.

The P/B ratio of Medpace Holdings Inc (MEDP) is 11.57 times as on 06-Nov-2024, a 257% premium to its peers’ median range of 3.24 times.

The P/E ratio of Medpace Holdings Inc (MEDP) is 28.74 times as on 06-Nov-2024.

Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Medpace Holdings Inc (MEDP) and enter the required number of quantities and click on buy to purchase the shares of Medpace Holdings Inc (MEDP).

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio. Address: 5375 Medpace Way, Cincinnati, OH, United States, 45227

The CEO & director of Dr. August James Troendle M.D.. is Medpace Holdings Inc (MEDP), and CFO & Sr. VP is Dr. August James Troendle M.D..

There is no promoter pledging in Medpace Holdings Inc (MEDP).

Medpace Holdings Inc. (MEDP) Ratios
Return on equity(%)
47.09
Operating margin(%)
20.53
Net Margin(%)
17.66
Dividend yield(%)
--

No, TTM profit after tax of Medpace Holdings Inc (MEDP) was $0 Mln.